Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Flurbiprofen inhibits heterotopic bone formation in total hip arthroplasty.

Hoikka V, Lindholm TS, Eskola A.

Arch Orthop Trauma Surg. 1990;109(4):224-6.

PMID:
2116817
2.

Serum alkaline phosphatase as an indicator of heterotopic bone formation following total hip arthroplasty.

Kjaersgaard-Andersen P, Pedersen P, Kristensen SS, Schmidt SA, Pedersen NW.

Clin Orthop Relat Res. 1988 Sep;(234):102-9.

PMID:
3136963
3.

Short-course indomethacin prevents heterotopic ossification in a high-risk population following total hip arthroplasty.

Amstutz HC, Fowble VA, Schmalzried TP, Dorey FJ.

J Arthroplasty. 1997 Feb;12(2):126-32.

PMID:
9139094
4.

Heterotopic bone formation prevented by diclofenac. Prospective study of 100 hip arthroplasties.

Wahlström O, Risto O, Djerf K, Hammerby S.

Acta Orthop Scand. 1991 Oct;62(5):419-21.

PMID:
1950483
5.

Ketorolac prophylaxis against heterotopic ossification after hip replacement.

Pritchett JW.

Clin Orthop Relat Res. 1995 May;(314):162-5.

PMID:
7634630
7.

Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy.

Seegenschmiedt MH, Keilholz L, Martus P, Goldmann A, Wölfel R, Henning F, Sauer R.

Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):161-71.

PMID:
9300751
8.

Short term prophylaxis against heterotopic bone after cementless hip replacement.

Wurnig C, Auersperg V, Boehler N, Steindl M, Kiss H, Zweymuller K, Kotz R.

Clin Orthop Relat Res. 1997 Jan;(334):175-83.

PMID:
9005911
9.

The suppression of heterotopic ossification after total hip arthroplasty.

Reis HJ, Küsswetter W, Schellinger T.

Int Orthop. 1992;16(2):140-5.

PMID:
1428312
10.

Effect of ibuprofen on heterotopic ossification after hip replacement.

Elmstedt E, Lindholm TS, Nilsson OS, Törnkvist H.

Acta Orthop Scand. 1985 Feb;56(1):25-7.

PMID:
3920862
11.

[Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].

Kölbl O, Flentje M, Eulert J, Barthel T, Knelles D, Kraus U.

Strahlenther Onkol. 1997 Dec;173(12):677-82. German.

PMID:
9454352
12.

Usefulness of postoperative hip irradiation in the prevention of heterotopic bone formation in a high risk group of patients.

MacLennan I, Keys HM, Evarts CM, Rubin P.

Int J Radiat Oncol Biol Phys. 1984 Jan;10(1):49-53.

PMID:
6421784
13.

Naproxen prevention of heterotopic ossification after hip arthroplasty. A prospective control study of 55 patients.

Gebuhr P, Soelberg M, Orsnes T, Wilbek H.

Acta Orthop Scand. 1991 Jun;62(3):226-9.

PMID:
1904183
14.

Combined radiotherapy and indomethacin for the prevention of heterotopic ossification after total hip arthroplasty.

Pakos EE, Stafilas KS, Tsekeris PG, Politis AN, Mitsionis G, Xenakis TA.

Strahlenther Onkol. 2009 Aug;185(8):500-5. doi: 10.1007/s00066-009-1954-3. Epub 2009 Aug 4.

PMID:
19652932
15.
16.

Heterotopic bone formation following hip arthroplasty. A retrospective study of 65 bilateral cases.

Kjaersgaard-Andersen P, Steinke MS, Hougaard K, Søjbjerg JO, Jensen J.

Acta Orthop Scand. 1991 Jun;62(3):223-5.

PMID:
1904182
17.

Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties.

Kjaersgaard-Andersen P, Nafei A, Teichert G, Kristensen O, Schmidt SA, Keller J, Lucht U.

Acta Orthop Scand. 1993 Dec;64(6):639-42.

PMID:
8291408
18.

Heterotopic bone formation after total hip arthroplasty.

Thomas BJ.

Orthop Clin North Am. 1992 Apr;23(2):347-58. Review.

PMID:
1570146
19.

No effective prophylaxis of heterotopic ossification with short-term ibuprofen.

Koorevaar CT, Hu HP, Lemmens A, van Kampen A.

Arch Orthop Trauma Surg. 1999;119(3-4):183-5.

PMID:
10392515
20.

Indomethacin for prevention of heterotopic ossification after total hip arthroplasty.

Tözün R, Pinar H, Yeşiller E, Hamzaoğlu A.

J Arthroplasty. 1992 Mar;7(1):57-61.

PMID:
1564466

Supplemental Content

Support Center